|
⚲
|
| Keyboard |
| Requadt Scott
✚
|
|
|---|---|
| CIK # | 0001664852 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001664852] | |
| 4 | [0001664852] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
ESSA Pharma Inc EPIX
Common Shares
|
2025-10-09 | Disposed to issuer | 30,002 | ||
|
ESSA Pharma Inc EPIX
Options · derivative
|
2024-03-25 | Grant | 50,000 | $0.00 | |
|
ESSA Pharma Inc EPIX
Common Shares
|
2023-11-06 | Other | 12,500 | $0.00 | |
|
ESSA Pharma Inc EPIX
Common Shares
|
2023-10-30 | Other | 17,502 | $0.00 | |
|
Tourmaline Bio Inc TALS
Common Stock
|
2023-07-03 | Tax withheld | 11,786 | $3.08 | 36,301 |
|
Tourmaline Bio Inc TALS
Stock Appreciation Right · derivative
|
2023-02-01 | Grant | 320,000 | $0.00 | |
|
Tourmaline Bio Inc TALS
Stock Option (Right to Buy) · derivative
|
2023-02-01 | Grant | 320,000 | $0.00 | |
|
Tourmaline Bio Inc TALS
Common Stock
|
2022-12-30 | Grant | 4 | $0.87 | 3 |
|
Tourmaline Bio Inc TALS
Common Stock
|
2022-09-10 | Grant | 80,000 | $0.00 | |
|
Tourmaline Bio Inc TALS
Common Stock
|
2022-07-29 | Buy | 39,382 | $4.25 | 167,374 |
|
Tourmaline Bio Inc TALS
Common Stock
|
2022-07-28 | Buy | 3,090 | $4.25 | 13,132 |
|
Tourmaline Bio Inc TALS
Common Stock
|
2022-07-26 | Buy | 5,528 | $4.24 | 23,439 |
|
Tourmaline Bio Inc TALS
Common Stock
|
2022-07-22 | Buy | 9,444 | $3.75 | 35,415 |
|
ESSA Pharma Inc EPIX
Stock Option (Right to Buy) · derivative
|
2022-06-29 | Grant | 22,500 | $0.00 | |
|
Tourmaline Bio Inc TALS
Stock Option (Right to Buy) · derivative
|
2022-02-01 | Grant | 500,000 | $0.00 | |
|
Tourmaline Bio Inc TALS
Common Stock
|
2021-12-31 | Grant | 1,470 | $13.00 | 19,110 |
|
ESSA Pharma Inc EPIX
Stock Option (Right to Buy) · derivative
|
2020-12-11 | Grant | 16,500 | $0.00 | |
|
VBI Vaccines Inc/BC VBIV
Option (Right to Buy Common Shares) · derivative
|
2019-01-31 | Grant | 200,000 | $0.00 | |
|
Entasis Therapeutics Holdings Inc ETTX
Series B-1 Tranche B Convertible Preferred Stock · derivative
|
2018-09-28 | Conversion | 8,552,024 | $0.00 | |
|
Entasis Therapeutics Holdings Inc ETTX
Series B-1 Tranche A Convertible Preferred Stock · derivative
|
2018-09-28 | Conversion | 6,702,213 | $0.00 | |
| showing 20 of 42 most recent transactions | |||||